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Generally, chlorinated phenols have strong
biological effects. Of all chlorinated phenols,
pentachlorophenol (PCP) seems to have been
produced and used in the largest quantities;
annual production of PCP all over the world
was estimated to be 25,000–90,000 tons at
its peak (1). Because PCP is inexpensive and
has potent biocidal effects against a broad
spectrum of species, PCP and its salts have
been used as algicides, bactericides, fungi-
cides, herbicides, insecticides, and mollus-
cides (2). Although its use has been reduced
greatly and even banned in some countries,
PCP is still used widely in the preservation of
wood (1,2). Hence, PCP is ubiquitous in the
environment. For instance, it has been
detected in ambient air of rural mountain
areas, and PCP levels of 5.7–7.8 ng/m3 have
been found in urban areas (2). PCP concen-
trations in groundwater can be 3–23 µg/L in
wood-treatment areas and concentrations in
the milligrams per liter range can be found
near industrial discharges. As a result, the
general population is exposed to PCP
through the ingestion of water (0.01–0.1
µg/L) and food (up to 40 µg/kg). People may
be exposed to PCP in treated items such as
textiles, leather, and paper products, and
especially through inhalation of indoor air
contaminated with PCP; PCP concentrations
up to 25 µg/m3 have been found in rooms
treated 1 to several years earlier (2). Workers
handling PCP can be exposed to much
higher doses of PCP (1). Thus, health effects
of PCP among workers, as well as among the
general population, are of great concern.
Acute exposures to high doses of PCP in
accidental or suicidal intoxication are often
fatal and are associated with extreme weak-
ness, hyperpyrexia, and profuse sweating
(2). These signs can be explained by the
effects of PCP itself, that is, uncoupling of
oxidative phosphorylation in mitochondria
(3). In contrast, although effects of lower
doses of PCP and tetrachlorohydroquinone
(TCHQ), the major metabolite of PCP (4),
on diverse biological systems (including the
immune system) have been suggested (5–9),
neither clinical pictures nor mechanisms of
their effects have been clarified. We there-
fore examined effects of PCP and TCHQ
on mitogen-activated protein kinases
(MAPKs)—extracellular signal-regulated
protein kinase (ERK), p38, and c-Jun NH2-
terminal kinase (JNK)—in a human T-cell
line (Jurkat cells) because recent studies
have shown that MAPKs play important
roles in cellular responses to various harmful
signals (10).
Materials and Methods
Cell culture and treatments. Jurkat human T
cells (RIKEN Cell Bank, Tsukuba, Japan)
were grown in RPMI 1640 media supple-
mented with 10% heat-inactivated fetal
bovine serum, 100 units/mL penicillin, and
100 µg/mL streptomycin (GIBCO BRL,
Life Technologies, Inc., Rockville, MD,
USA) in a humidified atmosphere of 5%
CO2 and 95% air at 37°C. Exponentially
growing Jurkat cells were diluted at 3 × 106
cells in 6-well culture plates or 1 × 105 cells
in 96-well culture plates and subsequently
used for the experiments.
For each experiment, we prepared fresh
solutions of PCP (Sigma Chemical Co., St.
Louis, MO, USA) and TCHQ (Sigma
Chemical Co.) with dimethyl sulfoxide
(DMSO). Jurkat cells were incubated with
serum-free medium containing 5–20 µM
PCP or TCHQ for 1 or 10 hr at 37°C.
Untreated control cells were incubated with
serum-free medium containing the same
concentration of DMSO (0.1–0.3%) and
were treated identically to the cells exposed
to PCP or TCHQ.
The MAPK/ERK kinase (MEK) inhibitor
U0126 (Promega, Madison, WI, USA) and
a specific inhibitor of p38, SB203580
(Calbiochem, La Jolla, CA, USA) were dis-
solved in DMSO. Cells were preincubated
with serum-free medium containing either
0.1–0.2% DMSO, 50 µM U0126, 50 µM
SB203580, or 50 µM U0126 plus 50 µM
SB203580 for 30 min, and then incubated
with 0.1% DMSO, 20 µM PCP, or TCHQ
for 10 hr. A radicicol-related macrocyclic non-
aketide compound, LL-Z1640-2 (provided by
Pharmaceutical Research Laboratories,
Ajinomoto Co., Inc., Kawasaki, Japan), which
has been shown to inhibit the activation of
JNK (11,12), was also dissolved in DMSO.
Cells were preincubated with serum-free
medium containing either 0.002% DMSO
or 50, 100, or 200 ng/mL LL-Z1640-2 for
30 min and then incubated with 0.1%
DMSO or 20 µM TCHQ for 10 hr.
WST-8 assay. We determined cell via-
bility using the WST-8 assay. Cell Count
Reagent SF (10 µL; Nacalai Tesque,
Kyoto, Japan), which consists of 5 mM
WST-8 (4-[3-(2-methoxy-4-nitrophenyl)-
2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-
benzene disulfonate sodium salt), 0.2 mM
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When Jurkat human T cells were incubated with 20 µM of pentachlorophenol (PCP) or its
metabolite, tetrachlorohydroquinone (TCHQ), for 10 hr, flow cytometric analyses revealed
marked increase in the number of apoptotic cells. DNA fragmentation was also observed in these
cells. TCHQ was more potent than PCP in causing apoptosis. After incubation with 20 µM
TCHQ for 1 hr, all mitogen-activated protein kinases (MAPKs) examined [i.e., extracellular sig-
nal-regulated protein kinase (ERK), p38, and c-Jun NH2-terminal kinase (JNK)] were phosphory-
lated, whereas no clear phosphorylation was induced by PCP. TCHQ-induced apoptosis was
markedly suppressed by treatment with a p38 inhibitor (SB203580) and mildly (but signiﬁcantly)
suppressed by treatment with a MAPK/ERK kinase inhibitor (U0126). When cells were treated
with both inhibitors at the same time, TCHQ-induced apoptosis disappeared almost completely.
PCP-induced apoptosis was also suppressed by SB203580 and/or U0126. Nevertheless, treatment
with LL-Z1640-2, which inhibits JNK phosphorylation, did not suppress the apoptosis caused by
either TCHQ or PCP. Thus, p38 and ERK appear to be important signal transduction pathways
leading to apoptosis in a human T-cell line exposed to a ubiquitous pollutant or its metabolite in
the general and occupational environment. Key words: apoptosis, Jurkat cells, mitogen-activated
protein kinases, pentachlorophenol, tetrachlorohydroquinone. Environ Health Perspect
110:139–143 (2002). [Online 10 January 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p139-143wispriyono/abstract.html1-methoxy-5-methylphenazinium methosul-
fate, and 150 mM NaCl, was added to each
well of 96-well culture plates. After incuba-
tion for 1 hr at 37°C, the absorbance of each
well was measured at 450 nm with a refer-
ence wavelength at 655 nm.
Flow cytometric analysis. Jurkat cells (3 ×
106) incubated with PCP or TCHQ for 10
hr were washed with phosphate-buffered
saline (PBS) and ﬁxed in 70% ethanol on ice
for 30 min. The ﬁxed cells were washed twice
with PBS, incubated with 250 µg/mL RNase
at 37°C for 1 hr, washed again twice, and
then stained with 50 µg/mL propidium
iodide solution. The DNA content of cells (1
× 104 for each sample) was determined with
a Coulter EPICS XL (Coulter Electronics,
Miami, FL, USA). Apoptotic cells were esti-
mated by the percentage of cells in the sub-
G1 peak as described previously (13).
DNA fragmentation. We performed
DNA fragmentation analysis using the
method of Herrmann et al. (14) with slight
modifications. After the incubation with
PCP or TCHQ for 10 hr, Jurkat cells were
washed with PBS and treated with lysis
buffer (1% NP-40, 20 mM EDTA, 50 mM
Tris-HCl, pH 7.5) for 30 min on ice. After
centrifugation at 1,600 g for 5 min, cell
lysates were incubated with 1% SDS and 5
mg/mL RNase for 2 hr at 56°C, and then
with 2.5 mg/mL proteinase K for 4 hr at
37°C. DNA was precipitated with 1/2 vol.
10 M ammonium acetate and 2.5 vol.
ethanol, dissolved in loading buffer, sepa-
rated by electrophoresis in 1.5% agarose gel
containing 0.5 µg/mL ethidium bromide,
and visualized under UV light.
Western immunoblotting. After incuba-
tion with PCP or TCHQ for 1 hr, Jurkat
cells were washed with PBS and lysed with
SDS-polyacrylamide gel Laemmli sample
buffer. Cell lysates were collected, sonicated,
and boiled for 5 min. Aliquots equivalent to
4 × 105 cells were subjected to SDS-PAGE
on a 10% polyacrylamide gel and transferred
to a nitrocellulose membrane (Hybond-
ECL, Amersham Pharmacia Biotech,
Buckinghamshire, England). The membrane
was blocked with 5% nonfat milk or 1%
bovine serum albumin in Tris-buffered
saline containing 0.1% Tween-20 for 1 hr at
room temperature. We used the following
antibodies: phospho-p44/42 MAPK (Thr202/
Tyr204) antibody, phosphorylation state-
independent p44/42 MAPK antibody, phos-
pho-p38 MAPK (Thr180/Tyr182) antibody,
phosphorylation state-independent p38
MAPK antibody, phospho-SAPK/JNK
(Thr183/Tyr185) antibody, and phosphory-
lation state-independent SAPK/JNK anti-
body (Cell Signaling Technology, Inc.,
Beverly, MA, USA). The membrane was
incubated overnight at 4°C with the primary
antibody diluted 1:1000 in 5% bovine serum
albumin in Tris-buffered saline containing
0.1% Tween-20. We detected protein using
the Phototope-HRP Western blot detection
kit (Cell Signaling Technology, Inc.). The
bands on the developed ﬁlm were quantiﬁed
with NIH Image Version 1.61 (National
Institutes of Health, Bethesda, MD, USA).
Statistical analysis. Results were expressed
as mean ± SEM. We determined statistical
signiﬁcance using one-way analysis of variance
followed by the Bonferroni multiple compari-
son test. When two groups were compared,
we used the Student t-test. p < 0.05 was con-
sidered as statistically signiﬁcant.
Results
The cell viability of Jurkat cells assayed with
WST-8 conversion was 92.2 ± 0.9, 79.8 ±
1.7, and 74.9 ± 1.2%, respectively, for cells
treated with 5, 10, and 20 µM TCHQ for
10 hr and 99.8 ± 1.5, 97.5 ± 1.1, and 85.5 ±
0.5% (n = 4) of untreated control cells for
those treated with 5, 10, and 20 µM PCP
for 10 hr, respectively. Thus, TCHQ treat-
ment reduced cell viability more than PCP
treatment at each concentration (p < 0.01).
When Jurkat cells were incubated with
20 µM TCHQ for 10 hr, a marked increase
in the number of apoptotic cells was found
with flow cytometric analysis (Figure 1).
Incubation with 20 µM PCP for 10 hr also
increased the number of apoptotic cells, but
this increase was less significant than that
with the same dose of TCHQ (p < 0.05;
Figure 1). Consistent with the results of ﬂow
cytometric analysis, DNA fragmentation
occurred in cells treated with 20 µM TCHQ
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Figure 1. Apoptosis in Jurkat cells exposed to TCHQ or PCP. (A) Representative ﬂow cytometric analysis of cells incubated with 0.1% DMSO, 5 µM TCHQ, 10 µM
TCHQ, 20 µM TCHQ, 5 µM PCP, 10 µM PCP, or 20 µM PCP for 10 hr at 37°C; apoptotic (Ap) and G0–G1 cell populations are indicated by arrows. (B) Percentage of
apoptosis in control cells and cells exposed to TCHQ or PCP. Apoptotic cells were estimated by the percentage of cells in the sub-G1 peak. Each bar represents
the mean ± SEM of three independent experiments. 
**p < 0.05 versus control (0.1% DMSO). 
Figure 2. DNA fragmentation in Jurkat cells
exposed to TCHQ (lanes 2–5) or PCP (lanes 6–9).
Cells were incubated with TCHQ or PCP for 10 hr.
Isolated DNA was run on a 1.5% agarose gel con-
taining ethidium bromide. Lane 1, 0.1% DMSO;
lane 2, 5 µM TCHQ; lane 3, 7.5 µM TCHQ; lane 4, 10
µM TCHQ; lane 5, 20 µM TCHQ; lane 6, 5 µM PCP;
lane 7, 7.5 µM PCP; lane 8, 10 µM PCP; lane 9, 20
µM PCP.
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9). In contrast, incubation with TCHQ or
PCP at concentrations higher than 20 µM
induced apoptosis less markedly (data
not shown).
We determined the phosphorylation sta-
tus of MAPKs after incubation with TCHQ
or PCP for 1 hr, when cell viability of Jurkat
cells was not changed as evaluated by the
WST-8 assay (data not shown). After incu-
bation with TCHQ for 1 hr, we found sig-
nificant phosphorylation of ERK (Figure
3A), p38 (Figure 3B), and JNK (Figure 3C)
at 20, 10, and 7.5 µM TCHQ, respectively.
In contrast, incubation with PCP did not
induce clear phosphorylation of MAPKs
(Figure 3). The levels of total (phosphoryla-
tion state-independent) ERK, p38, and JNK
were not changed by the incubation with
any concentration of TCHQ or PCP (Figure
3). In the time-course study, the levels of the
phosphorylated form of ERK and p38
increased after 15 min and that of JNK
increased after 1 hr in response to 20 µM
TCHQ exposure (data not shown).
Treatment with an MEK inhibitor,
U0126 (50 µM), suppressed the TCHQ-
induced increase in the number of apoptotic
cells mildly but signiﬁcantly (p < 0.01; Figure
4). In contrast, treatment with a p38
inhibitor, SB203580 (50 µM), protected cells
more markedly from TCHQ-induced apop-
tosis (Figure 4). The difference in the magni-
tude of suppression of apoptosis between
cells treated with U0126 and SB203580 was
signiﬁcant (p < 0.01; Figure 4B). When cells
were treated with U0126 (50 µM) and
SB203580 (50 µM) at the same time,
TCHQ-induced apoptosis was abolished
almost completely (Figure 5). Treatment
with U0126, SB203580, or both compounds
together also reduced the number of apop-
totic cells in Jurkat cells treated with PCP
(25.8 ± 0.7%, n = 6) to 21.4 ± 0.6% (p <
0.05, n = 3), 13.0 ± 0.8% (p < 0.001, n = 3),
and 5.7 ± 0.3% (p < 0.001, n = 3), respec-
tively. In contrast, treatment with > 50
ng/mL LL-Z1640-2, the concentration that
suppressed TCHQ-induced phosphorylation
of JNK (data not shown), did not reduce the
number of apoptotic cells in cells treated with
TCHQ (Figure 6). However, treatment with
LL-Z1640-2 (200 ng/mL) alone did not
induce apoptosis (Figure 6).
Discussion
Both ﬂow cytometric and DNA fragmenta-
tion analyses indicated apoptosis in Jurkat
cells treated with 20 µM PCP or 20 µM
TCHQ for 10 hr. The flow cytometry
showed that apoptosis was more marked
when cells were incubated with TCHQ
than with PCP. Consistent with this, the
WST-8 assay showed that treatment with
TCHQ reduced cell viability more
markedly than treatment with the same dose
of PCP. Wang and colleagues (15,16)
reported that TCHQ induced apoptosis in
mouse ﬁbroblasts and human bladder carci-
noma cells, but not in human liver cells,
whereas PCP induced no apoptosis in either
human cells (16). These findings and ours
suggest that exposure to PCP or TCHQ
induces apoptosis depending on the cell
type and that human lymphocytes are sensi-
tive to both PCP and TCHQ, but more so
to TCHQ. TCHQ has been detected in
urine of humans occupationally exposed to
PCP (17,18). The concentration of PCP
found in blood from workers exposed to
PCP (4,730 µg/L) (19) was similar to the
concentration we used in the present study
(20 µM PCP). Thus, lowered lymphocyte
count seen in workers with high PCP con-
centrations in blood (9) might be due to
apoptotic cell death of lymphocytes.
However, it should be noted that we
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Environmental Health Perspectives • VOLUME 110 | NUMBER 2 | February 2002 141
Figure 4. Effects of U0126 or SB203580 on TCHQ-induced apoptosis in Jurkat cells. (A) Representative ﬂow cytometric analysis of cells treated with 0.2% DMSO
for 10 hr, 20 µM TCHQ for 10 hr, 50 µM U0126 for 30 min plus 20 µM TCHQ for 10 hr, or 50 µM SB203580 for 30 min plus 20 µM TCHQ for 10 hr; apoptotic (Ap) and
G0–G1 cell populations are indicated by arrows. (B) Apoptotic cells estimated by the percentage of cells in the sub-G1 peak; each bar represents the mean ± SEM
of three independent experiments. 
*p < 0.001 versus control (0.2% DMSO); #p < 0.01; ##p < 0.001 versus TCHQ.
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Figure 3. Dose effects of TCHQ and PCP on the accumulation of (A) phosphorylated (Phospho) ERK, (B) p38, and (C) JNK. Jurkat cells were incubated with TCHQ
or PCP for 1 hr, and cell lysates were subjected to Western immunoblotting. The levels of phosphorylated ERK, p38, and JNK were determined on the basis of
densitometric analyses. Each value is expressed as the ratio of phosphorylated MAPK to the corresponding total MAPK, and the control value was set to 1. Bars
indicate the mean ± SEM of three independent experiments.
**p < 0.05; #p < 0.01 versus control (0.1% DMSO). 
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Concentration (µM) Concentration (µM)observed apoptosis in Jurkat cells that were
incubated with PCP or TCHQ in the
absence of serum, whereas more than 96%
PCP may be bound to human plasma pro-
tein (20). Hence, it remains to be deter-
mined whether apoptosis is induced in
peripheral lymphocytes following exposures
to PCP or TCHQ in vivo as well.
MAPKs are a family of serine/threonine
protein kinases that transmit extracellular
signals into the nucleus (21). Three subfam-
ilies of MAPKs have been identified: ERK,
p38, and JNK, which is also known as
stress-activated protein kinase or SAPK.
MAPK cascades have been shown to partici-
pate in a diverse array of cellular functions
such as cell growth, differentiation, and
apoptosis (10,21). Previously, we found that
heavy metals that can affect the immune
system, such as cadmium, inorganic mer-
cury, and organotin compounds, activate
MAPKs in CCRF-CEM human lym-
phoblastoid cells prior to the development
of apoptosis (12,13,22). We therefore deter-
mined the phosphorylation status of ERK,
p38, and JNK in Jurkat human T cells
treated with PCP or TCHQ. As a result, we
found that treatment with TCHQ induced
marked phosphorylation of p38 as well as
ERK and JNK in Jurkat cells without
changing the total protein levels of each
MAPK. In contrast to the treatment with
TCHQ, treatment with PCP did not
induce MAPK phosphorylation clearly at
the same doses (5–20 µM) and incubation
period (1 hr).
TCHQ has been found to induce DNA
single-strand breaks and increase the level of
8-hydroxy-2-deoxyguanosine, whereas these
effects were not observed after exposures to
PCP (23–25). Therefore, TCHQ and PCP
may differ in their potentials to damage
DNA, and that might account for the dif-
ferences in MAPK phosphorylation and
subsequent development of apoptosis.
MAPKs can be activated in response to
other chlorinated compounds. For example,
polychlorinated biphenyls, 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD), and
o,p´-dichlorodiphenyltrichloroethane (o,p´-
DDT) have been reported to activate ERK
and JNK in various types of cells (26–32).
Unpurified technical grade PCP is often
contaminated with other chlorinated com-
pounds including PCBs, TCDD, and o,p´-
DDT (1,2). It is therefore possible that
alterations of lymphocytes seen in workers or
in the general population may be partly due
to effects of these contaminants. However,
our results do not appear to be affected by
contaminants because we used puriﬁed PCP
and TCHQ.
The responses to inhibitors of MAPKs
observed in the present experiments are
consistent with the involvement of MAPK
phosphorylation in TCHQ or PCP-
induced apoptosis. SB203580, a p38
inhibitor (33), suppressed apoptosis
markedly, and U0126, a potent inhibitor of
both activated and nonactivated forms of
MEK1/2 (34), also suppressed apoptosis
mildly but significantly. When cells were
treated with both inhibitors at the same
time, TCHQ-induced apoptosis disap-
peared almost completely. These observa-
tions indicate that p38 and ERK play a
major role in TCHQ-induced apoptosis to
a different extent and that the two path-
ways might work synergistically. Because
PCP-induced apoptosis was also suppressed
by SB203580 and U0126, inhibition of
basally activated forms of p38 and ERK
might be partially effective. In contrast,
treatment with LL-Z1640-2, which sup-
presses JNK phosphorylation (11,12), did
not protect cells from apoptosis. This indi-
cates that although JNK phosphorylation
was most marked among the MAPKs exam-
ined, JNK did not play a major role leading
to the apoptosis.
PCP inhibits oxidative phosphorylation
(3) and also induces morphologic alter-
ations in the mitochondria (35). Therefore,
to clarify the mechanisms of PCP- and
TCHQ-induced apoptosis, mitochondrial
functions including membrane potential
and cytochrome c release remain to be
determined.
Thus, the present results indicate that
some effects of PCP and its metabolite may
be prevented by modifying MAPK path-
ways. However, more experiments are neces-
sary before such an application is considered
because their in vivo effects have not
been clariﬁed.
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Figure 5. Effects of the combined treatment of
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